DK1173418T3 - Krystallinsk form 3 af natriumsaltet af 5-chlor-2-methoxy-N (2- (4-methoxy-3-methylaminothiocarbonyl-aminosulfonylphenyl) ethyl) benzamid - Google Patents
Krystallinsk form 3 af natriumsaltet af 5-chlor-2-methoxy-N (2- (4-methoxy-3-methylaminothiocarbonyl-aminosulfonylphenyl) ethyl) benzamidInfo
- Publication number
- DK1173418T3 DK1173418T3 DK00926805T DK00926805T DK1173418T3 DK 1173418 T3 DK1173418 T3 DK 1173418T3 DK 00926805 T DK00926805 T DK 00926805T DK 00926805 T DK00926805 T DK 00926805T DK 1173418 T3 DK1173418 T3 DK 1173418T3
- Authority
- DK
- Denmark
- Prior art keywords
- methoxy
- methylaminothiocarbonyl
- aminosulfonylphenyl
- benzamide
- chloro
- Prior art date
Links
- -1 (2- (4-methoxy-3-methylaminothiocarbonyl-aminosulfonylphenyl) ethyl) benzamide Chemical compound 0.000 title 1
- 159000000000 sodium salts Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C335/40—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of thiourea or isothiourea groups further bound to other hetero atoms
- C07C335/42—Sulfonylthioureas; Sulfonylisothioureas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19917233A DE19917233A1 (de) | 1999-04-16 | 1999-04-16 | Kristalline Formen des Natriumsalzes des 5-Chlor-2-methoxy-N-(2-(4-methoxy-3-methylaminothiocarbonylaminosulfonyl-phenyl)-ethyl)- benzamids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1173418T3 true DK1173418T3 (da) | 2006-04-10 |
Family
ID=7904803
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK00926805T DK1173418T3 (da) | 1999-04-16 | 2000-04-04 | Krystallinsk form 3 af natriumsaltet af 5-chlor-2-methoxy-N (2- (4-methoxy-3-methylaminothiocarbonyl-aminosulfonylphenyl) ethyl) benzamid |
Country Status (33)
| Country | Link |
|---|---|
| US (1) | US6723751B1 (cs) |
| EP (2) | EP1637519B1 (cs) |
| JP (1) | JP4662640B2 (cs) |
| KR (1) | KR100700302B1 (cs) |
| CN (1) | CN1168712C (cs) |
| AR (1) | AR023479A1 (cs) |
| AT (2) | ATE311364T1 (cs) |
| AU (1) | AU773246B2 (cs) |
| BR (1) | BR0010658A (cs) |
| CA (1) | CA2370388C (cs) |
| CZ (1) | CZ302459B6 (cs) |
| DE (3) | DE19917233A1 (cs) |
| DK (1) | DK1173418T3 (cs) |
| EE (1) | EE04612B1 (cs) |
| ES (1) | ES2251996T3 (cs) |
| HK (1) | HK1046270B (cs) |
| HR (1) | HRP20010744B1 (cs) |
| HU (1) | HU229082B1 (cs) |
| IL (2) | IL145921A0 (cs) |
| ME (1) | MEP55708A (cs) |
| MX (1) | MXPA01010275A (cs) |
| MY (1) | MY122588A (cs) |
| NO (1) | NO327798B1 (cs) |
| NZ (1) | NZ514788A (cs) |
| PL (1) | PL203809B1 (cs) |
| RS (1) | RS50916B (cs) |
| RU (1) | RU2235089C2 (cs) |
| SI (1) | SI1173418T1 (cs) |
| SK (1) | SK287175B6 (cs) |
| TR (2) | TR200501142T2 (cs) |
| TW (1) | TWI276622B (cs) |
| WO (1) | WO2000063167A1 (cs) |
| ZA (1) | ZA200108400B (cs) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE534381T1 (de) * | 2003-03-17 | 2011-12-15 | Japan Tobacco Inc | Pharmazeutische cetp-inhibitor-zusammensetzungen |
| TWI393560B (zh) * | 2003-05-02 | 2013-04-21 | Japan Tobacco Inc | 包含ｓ-〔２（〔〔１-（２-乙基丁基）環己基〕羰基〕胺基）苯基〕２-甲基丙烷硫酯及ｈｍｇ輔酶ａ還原酶抑制劑之組合 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0612724B1 (de) | 1993-02-23 | 1996-12-27 | Hoechst Aktiengesellschaft | Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe- Verfahren zu ihrer Herstellung und ihre Verwendung als Pharmazeutika |
| DE19505397A1 (de) * | 1995-02-17 | 1996-08-22 | Hoechst Ag | Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| CN1195524C (zh) * | 1998-09-10 | 2005-04-06 | 阿文蒂斯药物德国有限公司 | 苯磺酰(硫)脲与β－受体阻滞剂联合在制备用于心脏迷走神经机能障碍治疗和预防的药物中的用途 |
-
1999
- 1999-04-16 DE DE19917233A patent/DE19917233A1/de not_active Withdrawn
-
2000
- 2000-04-04 AT AT00926805T patent/ATE311364T1/de active
- 2000-04-04 JP JP2000612263A patent/JP4662640B2/ja not_active Expired - Fee Related
- 2000-04-04 IL IL14592100A patent/IL145921A0/xx active IP Right Grant
- 2000-04-04 ES ES00926805T patent/ES2251996T3/es not_active Expired - Lifetime
- 2000-04-04 KR KR1020017013220A patent/KR100700302B1/ko not_active Expired - Fee Related
- 2000-04-04 EP EP05024254A patent/EP1637519B1/en not_active Expired - Lifetime
- 2000-04-04 RU RU2001130886/04A patent/RU2235089C2/ru not_active IP Right Cessation
- 2000-04-04 RS YUP-720/01A patent/RS50916B/sr unknown
- 2000-04-04 BR BR0010658-5A patent/BR0010658A/pt not_active IP Right Cessation
- 2000-04-04 EP EP00926805A patent/EP1173418B1/en not_active Expired - Lifetime
- 2000-04-04 MX MXPA01010275A patent/MXPA01010275A/es active IP Right Grant
- 2000-04-04 HK HK02107874.4A patent/HK1046270B/zh not_active IP Right Cessation
- 2000-04-04 CN CNB008063184A patent/CN1168712C/zh not_active Expired - Fee Related
- 2000-04-04 TR TR2005/01142T patent/TR200501142T2/xx unknown
- 2000-04-04 HR HR20010744A patent/HRP20010744B1/xx not_active IP Right Cessation
- 2000-04-04 NZ NZ514788A patent/NZ514788A/xx not_active IP Right Cessation
- 2000-04-04 AU AU45428/00A patent/AU773246B2/en not_active Ceased
- 2000-04-04 SK SK1458-2001A patent/SK287175B6/sk not_active IP Right Cessation
- 2000-04-04 CZ CZ20013672A patent/CZ302459B6/cs not_active IP Right Cessation
- 2000-04-04 ME MEP-557/08A patent/MEP55708A/xx unknown
- 2000-04-04 SI SI200030775T patent/SI1173418T1/sl unknown
- 2000-04-04 HU HU0200791A patent/HU229082B1/hu not_active IP Right Cessation
- 2000-04-04 CA CA002370388A patent/CA2370388C/en not_active Expired - Fee Related
- 2000-04-04 WO PCT/EP2000/002984 patent/WO2000063167A1/en not_active Ceased
- 2000-04-04 AT AT05024254T patent/ATE414059T1/de not_active IP Right Cessation
- 2000-04-04 PL PL351245A patent/PL203809B1/pl unknown
- 2000-04-04 EE EEP200100532A patent/EE04612B1/xx not_active IP Right Cessation
- 2000-04-04 TR TR2001/02993T patent/TR200102993T2/xx unknown
- 2000-04-04 DE DE60040811T patent/DE60040811D1/de not_active Expired - Lifetime
- 2000-04-04 DE DE60024431T patent/DE60024431T2/de not_active Expired - Lifetime
- 2000-04-04 DK DK00926805T patent/DK1173418T3/da active
- 2000-04-13 AR ARP000101712A patent/AR023479A1/es not_active Application Discontinuation
- 2000-04-14 US US09/549,538 patent/US6723751B1/en not_active Expired - Lifetime
- 2000-04-14 MY MYPI20001609A patent/MY122588A/en unknown
- 2000-05-10 TW TW089106840A patent/TWI276622B/zh not_active IP Right Cessation
-
2001
- 2001-10-12 ZA ZA200108400A patent/ZA200108400B/xx unknown
- 2001-10-14 IL IL145921A patent/IL145921A/en not_active IP Right Cessation
- 2001-10-15 NO NO20015014A patent/NO327798B1/no not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60004317D1 (de) | Salze von Sulfonium-Verbindungen | |
| IS2019B (is) | Nýtt kristallað form kalíumsalts (S)-ómeprasóls | |
| EE200100246A (et) | Asendatud fenüültsükloheksüülühendite uued esterderivaadid | |
| EP1174509A4 (en) | cytidine deaminase | |
| EE200300001A (et) | Perindopriili tert-butüülamiinsoola kristallilinealfa-vorm | |
| NO20030550L (no) | 17<beta>-karbotioat 17<alfa>-arylkarbonyloksyandrostanderivat som anti-inflammatoriske midler | |
| NL350038I1 (nl) | Herbicidaal actieve 3-hydroxy-4-aryl-5-oxopyrazoline derivaten | |
| DK1140034T3 (da) | Formulering af divalproex-natrium med kontrolleret frigivelse | |
| EE04120B1 (et) | Viirusevastase bensimidasoolühendi kristallilisedvormid | |
| NO20016319D0 (no) | VLA-4 inhibitor-forbindelser | |
| IS5870A (is) | Kristölluð form af EtO2C-CH2-(R)Cgl-Aze-Pab-OH | |
| HUP0202536A3 (en) | Crystals of the sodium salt of pravastatin | |
| NO20013684D0 (no) | Substituerte fenetylaminderivater | |
| ATE261431T1 (de) | Kristalline form von (s)-2-ethoxy-3-4-(2-4- methansulfonyloxyphenyl-ethoxy)phenyl)propansäu e | |
| DK1233960T3 (da) | Polymorft salt af anti-migræne lægemiddel | |
| ATE339438T1 (de) | Substanziell kristalline form von melagatran | |
| IS5821A (is) | Kristalluð form af ósanetant | |
| DK1173418T3 (da) | Krystallinsk form 3 af natriumsaltet af 5-chlor-2-methoxy-N (2- (4-methoxy-3-methylaminothiocarbonyl-aminosulfonylphenyl) ethyl) benzamid | |
| EE200100381A (et) | Morfolinobensamiidi uued soolad | |
| EE200100017A (et) | N-tert-butüülhüdroksüülamiini uued soolad | |
| DK1224179T3 (da) | Natrium-hydrogen-udbytter type 1-inhibitorkrystaller | |
| DK0980383T3 (da) | Farmaceutisk acceptable salte af 3-hydroxy-østr-5(10)-en-17-on-3-sulfat aktive som østrogener | |
| IS5544A (is) | Nýtt fosfatsalt af ísóprópýl-metýl-[2-(3-n-própoxýfenoxý)-etýl]amíni | |
| PL344006A1 (en) | Α-(1-piperazinyl)acetamido arenecarboxylic acid derivatives as antidiabetic agents |